GEHC
GE HealthCare Technologies Inc.
64.70$
-0.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +61.5% | -60.1% | -128.4% | – | +23.7% | -72.6% | -62.4% | +530.9% | +77.2% | -72.4% | -278.3% | – | |
| – | -5.9% | +2.8% | +0.7% | -4.0% | -2.1% | -2.9% | +8.8% | +0.0% | -1.4% | +4.8% | +4.6% | – | |
| – | +13.8% | +3.0% | +5.9% | -38.9% | +50.0% | -33.3% | +54.5% | +11.8% | -5.3% | -2.8% | +28.6% | – | |
| – | – | -27.7% | -410.4% | – | +147.1% | -166.5% | – | – | – | -165.0% | – | – | |
| – | +17.5% | +54.3% | -55.9% | +40.6% | +13.3% | +49.0% | -43.4% | +27.9% | +21.8% | +32.8% | -43.8% | – | |
| – | -26.7% | +113.6% | +85.6% | -60.7% | +75.2% | +69.6% | -45.2% | -33.6% | +81.8% | +829.4% | -95.4% | – | |
| – | -7.1% | +7.7% | +0.0% | -7.1% | +7.7% | +14.3% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | – | |
| – | – | – | – | – | – | – | – | +0.0% | -100.0% | – | +100.0% | – | |
| – | – | – | – | – | -227.2% | -79.6% | – | -100.3% | +6,425.0% | – | -106.1% | – | |
| – | +3,650.0% | -83.0% | -62.7% | – | -239.7% | -77.6% | – | -112.1% | +77.6% | – | -2,223.8% | – | |
| – | -81.9% | -31.4% | -1,027.1% | – | -143.7% | – | – | -79.5% | +83.7% | -559.2% | – | – | |
| – | +67.7% | -71.3% | -166.8% | – | +25.2% | -87.9% | -91.8% | +5,937.5% | +89.9% | -87.8% | -650.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.